The study drug was titrated based on weekly maternal capillary glucose values with targets of less than 95 mg/dL ( 5.3 mmol/L ) and 120 mg/dL ( 6.7 mmol/L ) for fasting and 2-hour postprandial glucose measurements , respectively .